Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supply Side West In Brief

This article was originally published in The Tan Sheet

Executive Summary

Zila: Orange-flavored Ester-C softchews will hit the market next year, Zila Nutraceuticals announced at the Supply Side West Trade Show & Conference in Las Vegas Sept. 29-Oct. 1. The 250 mg chew has been in development for more than two years. Television ads for Ester-C are breaking now and will run through March, reflecting the seasonal nature of vitamin C, while Ester-E spots are scheduled to air year-round. Radio ads featuring Larry King, now in their third season, complement the TV spots by targeting women aged 45 and older, and also represent an effort to "get closer to consumers," the Phoenix-based firm said. The promotional campaign is coordinated by Karlen Williams Graybill (New York) (1"The Tan Sheet" Aug. 18, 2003, p. 14). Zila said media spending for this year is double last year's, making the firm the fifth largest advertiser in the vitamin industry...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS097390

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel